NDC 19515-808

Flulaval Quadrivalent 2022/2023

Influenza Virus Vaccine

Flulaval Quadrivalent 2022/2023 is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Id Biomedical Corporation Of Quebec. The primary component is Influenza A Virus A/darwin/9/2021 Ivr-228 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated).

Product ID19515-808_c3c24138-25b9-4f0d-9c67-8640a023efe6
NDC19515-808
Product TypeVaccine
Proprietary NameFlulaval Quadrivalent 2022/2023
Generic NameInfluenza Virus Vaccine
Dosage FormSuspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-07-01
Marketing End Date2023-06-30
Marketing CategoryBLA /
Application NumberBLA125163
Labeler NameID Biomedical Corporation of Quebec
Substance NameINFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)
Active Ingredient Strength15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
NDC Exclude FlagN

Packaging

NDC 19515-808-52

10 SYRINGE in 1 CARTON (19515-808-52) > .5 mL in 1 SYRINGE (19515-808-41)
Marketing Start Date2022-07-01
Marketing End Date2023-06-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Flulaval Quadrivalent 2022/2023" or generic name "Influenza Virus Vaccine"

NDCBrand NameGeneric Name
58160-885FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-887FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-890FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-896FLUARIX QUADRIVALENTinfluenza virus vaccine
58160-898FLUARIX QUADRIVALENTinfluenza virus vaccine
19515-808Flulaval Quadrivalentinfluenza virus vaccine
19515-816Flulaval Quadrivalentinfluenza virus vaccine
19515-818Flulaval Quadrivalentinfluenza virus vaccine
19515-897Flulaval Quadrivalentinfluenza virus vaccine
19515-900Flulaval Quadrivalentinfluenza virus vaccine
19515-906Flulaval Quadrivalentinfluenza virus vaccine
19515-909Flulaval Quadrivalentinfluenza virus vaccine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.